VRCA
Verrica Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.30
−1.12%Margins
Gross margin
85.9%
EBITDA margin
-88.6%
EBIT margin
-92.8%
Net margin
-102.8%
FCF margin
-44.0%
-724.0%
Return on equity
-86.6%
Return on assets
-459.9%
Return on invested capital
0.81x
Asset turnover
-$13.3M
Cash from operations
$0.65
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026